The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 08, 2025

Filed:

May. 31, 2019
Applicant:

Sichuan University, Sichuan, CN;

Inventors:

Hang Zhao, Sichuan, CN;

Xin Zeng, Sichuan, CN;

Ning Ji, Sichuan, CN;

Hui Feng, Sichuan, CN;

Jiang Liu, Sichuan, CN;

Qianming Chen, Sichuan, CN;

Assignee:

SICHUAN UNIVERSITY, Sichuan, CN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/06 (2006.01); A61K 47/24 (2006.01); A61P 35/00 (2006.01); C07H 23/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/06 (2013.01); A61K 47/24 (2013.01); A61P 35/00 (2018.01); C07H 23/00 (2013.01);
Abstract

A bifunctional nucleoside hydrogel is formed by dissolving isoguanosine, guanosine and a borate in water or an aqueous solution and then crosslinking same. The bifunctional nucleoside hydrogel integrates a carrier and a drug effect and has a significant inhibitory effect on the activity of tumor cells, and in particular has a significant inhibitory effect on the activity of cells related to lung cancer, glioma, osteoma, colon cancer, breast cancer, oral squamous cell carcinoma and tongue squamous cell carcinoma, of which the inhibitory effect on the activity of cells related to oral squamous cell carcinoma is the best. Therefore, the bifunctional nucleoside hydrogel has potential application prospects in preparing anti-tumor drugs, and particularly, same can provide a new approach for treating oral squamous cell carcinoma.


Find Patent Forward Citations

Loading…